Literature DB >> 7690548

A mutation of furin causes the lack of precursor-processing activity in human colon carcinoma LoVo cells.

S Takahashi1, K Kasai, K Hatsuzawa, N Kitamura, Y Misumi, Y Ikehara, K Murakami, K Nakayama.   

Abstract

Furin has been proposed to be the endoprotease responsible for precursor cleavage at Arg-X-Lys/Arg-Arg (RXK/RR) sites within the constitutive secretory pathway. However, there was a possibility that other protease(s) is involved in this cleavage. We here characterized furin in human colon carcinoma LoVo cells, since these cells lacked the endogenous processing activity toward RXK/RR sites and recovered the activity by transfection of furin cDNA. Furin cDNA cloned from LoVo cells had one nucleotide deletion in the region covering the homo B domain which is essential for the endoproteolytic activity. LoVo cells transfected with a furin construct with the mutation showed no activity. Based on these data, we conclude that furin is the endoprotease that is involved in the precursor cleavage at RXK/RR sites within the constitutive secretory pathway.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690548     DOI: 10.1006/bbrc.1993.2146

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  45 in total

1.  Identification of inhibitors using a cell-based assay for monitoring Golgi-resident protease activity.

Authors:  Julia M Coppola; Christin A Hamilton; Mahaveer S Bhojani; Martha J Larsen; Brian D Ross; Alnawaz Rehemtulla
Journal:  Anal Biochem       Date:  2007-01-17       Impact factor: 3.365

2.  Mutagenesis of the DI/DIII linker in dengue virus envelope protein impairs viral particle assembly.

Authors:  Melissanne de Wispelaere; Priscilla L Yang
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  The Notch1 receptor is cleaved constitutively by a furin-like convertase.

Authors:  F Logeat; C Bessia; C Brou; O LeBail; S Jarriault; N G Seidah; A Israël
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

4.  Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function.

Authors:  R J Wool-Lewis; P Bates
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

5.  N-Linked Glycosylation-Dependent and -Independent Mechanisms Regulating CTRP12 Cleavage, Secretion, and Stability.

Authors:  Ashley N Stewart; Stefanie Y Tan; David J Clark; Hui Zhang; G William Wong
Journal:  Biochemistry       Date:  2019-01-04       Impact factor: 3.162

6.  Proteolytic activation of tick-borne encephalitis virus by furin.

Authors:  K Stadler; S L Allison; J Schalich; F X Heinz
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1.

Authors:  Y Ohnishi; T Shioda; K Nakayama; S Iwata; B Gotoh; M Hamaguchi; Y Nagai
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Engineered serine protease inhibitor prevents furin-catalyzed activation of the fusion glycoprotein and production of infectious measles virus.

Authors:  M Watanabe; A Hirano; S Stenglein; J Nelson; G Thomas; T C Wong
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX).

Authors:  Heike Liewen; Norbert Markuly; Heinz Läubli; Yang Liu; Matthias S Matter; Nora Liewen; Christoph Renner; Alfred Zippelius; Frank Stenner
Journal:  Target Oncol       Date:  2019-10       Impact factor: 4.493

10.  An activin/furin regulatory loop modulates the processing and secretion of inhibin alpha- and betaB-subunit dimers in pituitary gonadotrope cells.

Authors:  Monica Antenos; Jie Zhu; Niti M Jetly; Teresa K Woodruff
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.